Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12)
Document Type
- Journal article (11)
- Preprint (1)
Language
- English (12) (remove)
Keywords
- glycine receptor (6)
- hyperekplexia (3)
- startle disease (3)
- 3D cell cultures (1)
- 3D cultures (1)
- Alpha-synuclein oligomers (1)
- Alzheimer disease (1)
- Amyloid-beta oligomers; (1)
- Asc-1 transporter (1)
- Autism spectrum disorders (1)
- Cellular prion protein (1)
- Central nervous system (1)
- Cys-loop receptor (1)
- Dentate granule cells (1)
- Down syndrome (1)
- Familial Alzheimers-disease (1)
- Inhibitory glycine receptor (1)
- NMDAR (1)
- P75 Neurotrophin receptor (1)
- Temporal-lobe epilepsy (1)
- activation (1)
- anxiety (1)
- autism (1)
- autoantibody (aAb) (1)
- autoimmune antibodies (1)
- behavioral disorders (1)
- binding (1)
- candidate gene (1)
- channel (1)
- clinical neurology (1)
- domain (1)
- dominant (1)
- epilepsy (1)
- fast decay (1)
- fear (1)
- gephyrin (1)
- glycine receptor (GlyR) (1)
- glycine receptor autoantibodies (1)
- glycine transporter 2 (1)
- glycine uptake (1)
- glyvine uptake (1)
- human startle disease (1)
- ligand potencies (1)
- loop B (1)
- loss of function (1)
- mechanisms (1)
- mouse (1)
- mouse model (1)
- movement disorders (1)
- mutations (1)
- neurology (1)
- neuronal networks (1)
- presynaptic hyperekplexia (1)
- progressive encephalitis with rigidity and myoclonus (PERM) (1)
- protein maturation (1)
- protein transport (1)
- side chain properties (1)
- site (1)
- spastic (1)
- spinal cord neurons (1)
- startle (1)
- startle reaction (1)
- stiff-person syndrome (SPS) (1)
- structural disruption (1)
- synapses (1)
- trafficking (1)
- trafficking pathways (1)
- β8-β9 loop (1)
Synaptopathies: synaptic dysfunction in neurological disorders - a review from students to students
(2016)
Synapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept of synaptopathies as brain diseases with synapse defects as shared pathogenic features. In this review, which was initiated at the 13th International Society for Neurochemistry Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental disorders (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer and Parkinson disease). We finally discuss the appropriateness and potential implications of gathering synapse diseases under a single term. Understanding common causes and intrinsic differences in disease-associated synaptic dysfunction could offer novel clues toward synapse-based therapeutic intervention for neurological and neuropsychiatric disorders. In this Review, which was initiated at the 13th International Society for Neurochemistry (ISN) Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer's and Parkinson's diseases), gathered together under the term of synaptopathies. Read the Editorial Highlight for this article on page .
Ligand-binding of Cys-loop receptors is determined by N-terminal extracellular loop structures from the plus as well as from the minus side of two adjacent subunits in the pentameric receptor complex. An aromatic residue in loop B of the glycine receptor (GIyR) undergoes direct interaction with the incoming ligand via a cation-π interaction. Recently, we showed that mutated residues in loop B identified from human patients suffering from hyperekplexia disturb ligand-binding. Here, we exchanged the affected human residues by amino acids found in related members of the Cys-loop receptor family to determine the effects of side chain volume for ion channel properties. GIyR variants were characterized in vitro following transfection into cell lines in order to analyze protein expression, trafficking, degradation and ion channel function. GIyR α1 G160 mutations significantly decrease glycine potency arguing for a positional effect on neighboring aromatic residues and consequently glycine-binding within the ligand-binding pocket. Disturbed glycinergic inhibition due to T162 α1 mutations is an additive effect of affected biogenesis and structural changes within the ligand-binding site. Protein trafficking from the ER toward the ER-Golgi intermediate compartment, the secretory Golgi pathways and finally the cell surface is largely diminished, but still sufficient to deliver ion channels that are functional at least at high glycine concentrations. The majority of T162 mutant protein accumulates in the ER and is delivered to ER-associated proteasomal degradation. Hence, G160 is an important determinant during glycine binding. In contrast, 1162 affects primarily receptor biogenesis whereas exchanges in functionality are secondary effects thereof.